The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid
Open accessAbstract
Overexpression of histone deacetylase (HDAC) isoforms has been implicated in a variety of disease pathologies, from cancer and colitis to cardiovascular disease and neurodegeneration, thus HDAC inhibitors have a long history as therapeutic targets. The gut microbiota can influence HDAC activity via microbial-derived metabolites. While HDAC inhibition (HDI) by gut commensals has long been attributed to the short chain fatty acid (SCFA) butyrate, the potent metabolic reservoir provided by the gut microbiota and its role in host physiology warrants further investigation in a variety of diseases. Cell-free supernatants (CFS) of 79 phylogenetically diverse gut commensals isolated from healthy human donors were screened for their SCFA profile and their total HDAC inhibitory properties. The three most potent HDAC inhibiting strains were further evaluated and subjected to additional analysis of specific class I and class II HDAC inhibition. All three HDAC inhibitors are butyrate producing strains, and one of these also produced substantial levels of valeric acid and hexanoic acid. Valeric acid was identified as a potential contributor to the HDAC inhibitory effects. This bacterial strain, Megasphaera massiliensis MRx0029, was added to a model microbial consortium to assess its metabolic activity in interaction with a complex community. M. massiliensis MRx0029 successfully established in the consortium and enhanced the total and specific HDAC inhibitory function by increasing the capacity of the community to produce butyrate and valeric acid. We here show that single bacterial strains from the human gut microbiota have potential as novel HDI therapeutics for disease areas involving host epigenetic aberrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This SCFA is rather a rare bacterial metabolite generated by low-abundant commensals such as Megasphaera massiliensis, which we have classified as a pentanoate-producing bacterial species21.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [21]
In the citing paper
“Our broad screening approach revealed that among the commensal strains tested, only a few bacterial species exhibited a strong pan-HDAC inhibitory capacity21.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Gut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Formation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,938
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
New evidences on the altered gut microbiota in autism spectrum disorders
Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Calabrò, A., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0242-1 · Cited by 1,040
Gut microbes and the brain: paradigm shift in neuroscience
Mayer, E. A., Knight, R., Mazmanian, S. K., Cryan, J. F., & Tillisch, K. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3299-14.2014 · Cited by 1,033
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A., Grigorieva, E. F., Wilhelm, C., & Veldhoen, M. (2011) · Cell · doi:10.1016/j.cell.2011.09.025 · Cited by 837
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome
Markowiak‐Kopeć, P., & Śliżewska, K. (2020) · Nutrients · doi:10.3390/nu12041107 · Cited by 1,314
Luu, M., Riester, Z., Baldrich, A., Reichardt, N., Yuille, S., Busetti, A., Klein, M., Wempe, A., Leister, H., Raifer, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24331-1 · Cited by 771
Self-citationThe gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403
The interaction among gut microbes, the intestinal barrier and short chain fatty acids
Ma, J., Piao, X., Mahfuz, S. U., Long, S., & Wang, J. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.09.012 · Cited by 432
Nomura, M., Nagatomo, R., Doi, K., Shimizu, J., Baba, K., Saito, T., Matsumoto, S., Inoue, K., & Muto, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2895 · Cited by 396
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Akhtar, M. F., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., & Liu, H. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.11.005 · Cited by 398
Nishida, K., Sawada, D., Kuwano, Y., Tanaka, H., & Rokutan, K. (2019) · Nutrients · doi:10.3390/nu11081859 · Cited by 305
Ashaolu, T. J., Ashaolu, J. O., & Adeyeye, S. A. O. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14843 · Cited by 218
Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease
Qian, X., Xie, R.-Y., Liu, X., Chen, S., & Tang, H. (2022) · Aging and Disease · doi:10.14336/ad.2021.1215 · Cited by 234
O’Keefe, S. J. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30257-2 · Cited by 206
Gut commensal derived-valeric acid protects against radiation injuries
Li, Y., Dong, J., Xiao, H., Zhang, S., Wang, B., Cui, M., & Fan, S. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1709387 · Cited by 177
The Gut Microbiome and Sex Hormone-Related Diseases
He, S., Li, H., Yu, Z., Zhang, F., Liang, S., Liu, H., Chen, H., & Lü, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.711137 · Cited by 181
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
Fan, X., Jin, Y., Chen, G., Ma, X., & Zhang, L. (2020) · Digestion · doi:10.1159/000508328 · Cited by 176
Fawad, J. A., Luzader, D., Hanson, G. F., Moutinho, T. J., McKinney, C. A., Mitchell, P., Brown-Steinke, K., Kumar, A., Park, M., Lee, S., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2022.07.051 · Cited by 174
The role of short-chain fatty acids in inflammatory skin diseases
Xiao, X., Hu, X., Yao, J., Cao, W., Zou, Z., Wang, L., Qin, H., Zhong, D., Li, Y., Xue, P., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1083432 · Cited by 183
Chang, Y., Chen, Y., Zhou, Q., Wang, C., Chen, L., Di, W. J., & Zhang, Y. (2020) · Clinical Science · doi:10.1042/cs20191253 · Cited by 163
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 156
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
Arora, T., & Tremaroli, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761834 · Cited by 126
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
Kaur, H., & Ali, S. A. (2022) · Food & Function · doi:10.1039/d2fo00911k · Cited by 126
Dong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158200 · Cited by 107
“Pentanoate Clostridioides difficile; Megasphaera massiliensis (48) Increased the function of mTOR as a central cellular metabolic sensor and inhibited class I HDAC activity to enhance the anti-tumor activity of CTLs and CAR T cells (9), same as butyrate;”
BackgroundHuang, Y., Wang, Z., Ye, B., Hongjie, J., Ji, S., Sheng, W., Ye, S., Ou, Y., Peng, Y., Xu, Y., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04259-4 · Cited by 112
COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics
Qu, L., Cheng, Q., Wang, Y., Mu, H., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868086 · Cited by 104
Gut microbiota impacts bone via Bacteroides vulgatus-valeric acid-related pathways
Lin, X., Xiao, H.-M., Liu, H.-M., Lv, W.-Q., Greenbaum, J., Gong, R., Zhang, Q., Chen, Y.-C., Peng, C., Xu, X.-J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42005-y · Cited by 101
Ahmed, S., Busetti, A., Fotiadou, P., Jose, N. V., Reid, S., Georgieva, M., Brown, S., Dunbar, H., Beurket-Ascencio, G., Delday, M. I., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00402 · Cited by 100
Self-citationMoutsoglou, D., Tatah, J., Prisco, S. Z., Prins, K. W., Staley, C. M., Lopez, S., Blake, M., Teigen, L. M., Kazmirczak, F., Weir, Ε. K., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0490oc · Cited by 100
Bacterial Natural Compounds with Anti-Inflammatory and Immunomodulatory Properties (Mini Review)
Jenab, A., Roghanian, R., & Emtiazi, G. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s261283 · Cited by 97
Dürholz, K., Hofmann, J., Iljazović, A., Häger, J., Lucas, S., Sarter, K., Strowig, T., Bang, H., Rech, J., Schett, G. A., et al. (2020) · Nutrients · doi:10.3390/nu12103207 · Cited by 98
Shinde, T., Perera, A. P., Vemuri, R., Gondalia, S. V., Karpe, A. V., Beale, D. J., Shastri, S., Southam, B., Eri, R. D., & Stanley, R. A. (2019) · Nutrients · doi:10.3390/nu11040818 · Cited by 95
Shinde, T., Perera, A. P., Vemuri, R., Gondalia, S. V., Beale, D. J., Karpe, A. V., Shastri, S., Basheer, W., Southam, B., Eri, R. D., et al. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02200-9 · Cited by 92
The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome
Trujillo-Vargas, C. M., Schaefer, L., Alam, J., Pflugfelder, S. C., Britton, R. A., & de Paiva, C. S. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.10.006 · Cited by 87
Huang, Y., Ning, Z. H., Xing, Z., Liu, Y., Lu, H., Yin, X., Hao, H., Tan, Y. Q., Wang, D., Hu, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785422 · Cited by 90
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
Stec, A., Sikora, M., Maciejewska, M., Paralusz-Stec, K., Michalska, M. N., Sikorska, E., & Rudnicka, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043494 · Cited by 89
Vemuri, R., Gundamaraju, R., Shinde, T., Perera, A. P., Basheer, W., Southam, B., Gondalia, S. V., Karpe, A. V., Beale, D. J., Tristram, S. G., et al. (2019) · Nutrients · doi:10.3390/nu11061297 · Cited by 82
Trachsel, J., Briggs, C., Gabler, N. K., Allen, H. K., & Loving, C. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01381 · Cited by 87
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor
Wang, R. X., Henen, M. A., Lee, J. S., Vögeli, B., & Colgan, S. P. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1938380 · Cited by 87
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
King, J., Patel, M., & Chandrasekaran, S. (2021) · Metabolites · doi:10.3390/metabo11110792 · Cited by 78
The heightened importance of the microbiome in cancer immunotherapy
Villemin, C., Six, A., Neville, B. A., Lawley, T. D., Robinson, M. J., & Bakdash, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.002 · Cited by 81
Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 83
Qing, Y., Xie, H., Su, C. H., Wang, Y., Yu, Q., Pang, Q., & Cui, F. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5428-2 · Cited by 74
Kaur, H., Singh, Y., Singh, S., & Singh, R. B. (2020) · Genome · doi:10.1139/gen-2020-0136 · Cited by 75
Microbiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 77
Zhao, Q., Wang, Z., Wang, X., Yan, X., Guo, Q., Yue, Y., Yue, T., & Yuan, Y. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112493 · Cited by 72
Ratajczak, W., Mizerski, A., Rył, A., Słojewski, M., Sipak‐Szmigiel, O., Piasecka, M., & Laszczyńska, M. (2021) · Aging · doi:10.18632/aging.202968 · Cited by 70
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69
Gut Microbiota Composition Is Associated with the Global DNA Methylation Pattern in Obesity
Ramos-Molina, B., Sánchez-Alcoholado, L., Cabrera-Mulero, A., Lopez-Dominguez, R., Carmona-Saez, P., Garcia-Fuentes, E., Moreno-Indias, I., & Tinahones, F. J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00613 · Cited by 64
Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies
Hobson, S., Arefin, S., Witasp, A., Hernandez, L. N., Kublickiene, K. R., Shiels, P. G., & Stenvinkel, P. (2023) · Circulation Research · doi:10.1161/circresaha.122.321751 · Cited by 64
Gio-Batta, M., Sjöberg, F., Jonsson, K., Barman, M., Lundell, A., Adlerberth, I., Hesselmar, B., Sandberg, A., & Wold, A. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-79737-6 · Cited by 67
Rosés, C., Cuevas‐Sierra, A., Quintana, S., Riezu‐Boj, J. I., Martínez, J. A., Milagro, F. I., & Barceló, A. (2021) · Nutrients · doi:10.3390/nu13020636 · Cited by 71
Martínez-Gili, L., McDonald, J. A. K., Liu, Z., Kao, D. H., Allegretti, J. R., Monaghan, T. M., Barker, G. F., Blanco, J. M., Williams, H. R. T., Holmes, E. C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1810531 · Cited by 65
A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects
Mertowska, P., Mertowski, S., Wojnicka, J., Korona‐Głowniak, I., Grywalska, E., Błażewicz, A., & Załuska, W. (2021) · Nutrients · doi:10.3390/nu13103637 · Cited by 62
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 63
Chiu, L., & Gilbert, S. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817996-3.00015-3 · Cited by 55
Galow, A.-M., & Peleg, S. (2022) · Cells · doi:10.3390/cells11030468 · Cited by 60
The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis
Bărcuţean, L., Maier, S., Patrascu, M. B., Farczádi, L., & Bălașa, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063198 · Cited by 62
Thompson, K. N., Bonham, K. S., Ilott, N. E., Britton, G. J., Colmenero, P., Bullers, S. J., McIver, L. J., Ma, S., Nguyen, L. H., Filer, A. D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4722 · Cited by 57
Impact of Steviol Glycosides and Erythritol on the Human and Cebus apella Gut Microbiome
Mahalak, K. K., Firrman, J., Tomasula, P. M., Núñez, A., Lee, J., Bittinger, K. L., Rinaldi, W. J., & Liu, L. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06181 · Cited by 54
Tuck, C. J., Palma, G. D., Takami, K., Brant, B. J., Caminero, A., Reed, D. E., Muir, J. G., Gibson, P. R., Winterborn, A., Verdu, E. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74460-8 · Cited by 51
Zeng, X., Li, J., Shan, W., Lai, Z., & Zuo, Z. (2023) · Microbiome · doi:10.1186/s40168-023-01648-1 · Cited by 50
Colorectal Cancer and Probiotics: Are Bugs Really Drugs?
Lamichhane, P., Maiolini, M., Alnafoosi, O., Hussein, S., Alnafoosi, H., Umbela, S., Richardson, T., Alla, N., Lamichhane, N., Subhadra, B. G., et al. (2020) · Cancers · doi:10.3390/cancers12051162 · Cited by 50
Inamoto, T., Furuta, K., Cheng, H., Uneme, M., Kano, T., Ishikawa, K., & Kaito, C. (2023) · FEBS Journal · doi:10.1111/febs.16945 · Cited by 48
Thenappan, T., Khoruts, A., Chen, Y., & Weir, Ε. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00416.2019 · Cited by 46
Heppert, J. K., Davison, J. M., Kelly, C., Mercado, G. P., Lickwar, C. R., & Rawls, J. F. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00357-6 · Cited by 48
Dothel, G., Barbaro, M. R., Vito, A. D., Ravegnini, G., Gorini, F., Monesmith, S., Coschina, E., Benuzzi, E., Fuschi, D., Palombo, M., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-01997-6 · Cited by 49
Głowacka, P., Oszajca, K., Pudlarz, A. M., Szemraj, J., & Witusik‐Perkowska, M. (2024) · Nutrients · doi:10.3390/nu16142244 · Cited by 52
The Urine Metabolome of Young Autistic Children Correlates with Their Clinical Profile Severity
Mussap, M., Siracusano, M., Noto, A., Fattuoni, C., Riccioni, A., Rajula, H. S. R., Fanos, V., Curatolo, P., Barberini, L., & Mazzone, L. (2020) · Metabolites · doi:10.3390/metabo10110476 · Cited by 47
Microbiota-assisted iron uptake promotes immune tolerance in the intestine
Zhu, L., Li, G., Liang, Z., Qi, T., Deng, K., Yu, J., Peng, Y., Zheng, J., Song, Y., & Chang, X. (2023) · Nature Communications · doi:10.1038/s41467-023-38444-2 · Cited by 47
Butyrate-producing colonic clostridia: picky glycan utilization specialists
Leth, M. L., Pichler, M. J., & Hachem, M. A. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220125 · Cited by 43
Effects of valerate on intestinal barrier function in cultured Caco-2 epithelial cell monolayers
Gao, G., Zhou, J., Wang, H., Ding, Y., Zhou, J., Chong, P. H., Zhu, L., Ke, L., Wang, X., Rao, P., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-06991-w · Cited by 40
The Many Faces of Microbiota-Gut-Brain Axis in Autism Spectrum Disorder
Gonçalves, C. L., Doifode, T., Rezende, V. L., Costa, M. A., Rhoads, J. M., & Soutullo, C. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122357 · Cited by 42
Bashir, B., Gulati, M., Vishwas, S., Gupta, G., Dhanasekaran, M., Paudel, K. R., Chellappan, D. K., Anand, K., Negi, P., Singh, P. K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102689 · Cited by 45
Kim, G., Bae, J.-H., Cheon, S., Lee, D. H., Kim, D. H., Lee, D., Park, S., Shim, S., Seo, J., & Han, N. S. (2022) · Food & Function · doi:10.1039/d1fo03287a · Cited by 40
Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis
Liu, M., Zhang, Y., Liu, J., Xiang, C., Lu, Q., Lu, H., Yang, T., Wang, X., Zhang, Q., Fan, C., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad187 · Cited by 39
Cho, J. H., Chae, C. W., Lim, J. R., Jung, Y. H., Han, S. J., Yoon, J. H., Park, J. Y., & Han, H. J. (2024) · Autophagy · doi:10.1080/15548627.2024.2323785 · Cited by 42
The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients
Sabit, H., Kassab, A., Alaa, D., Mohamed, S., Abdel-Ghany, S. E., mansy, M. I. A., Said, O. A. M., Khalifa, M. A., Hafiz, H., & Abushady, A. M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050260 · Cited by 41
How gut microbiota may impact ocular surface homeostasis and related disorders
Labétoulle, M., Baudouin, C., del Castillo, J. M. B., Rolando, M., Rescigno, M., Messmer, E. S. B. M., & Aragona, P. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101250 · Cited by 38
Shinde, T., Vemuri, R., Shastri, S., Perera, A. P., Gondalia, S. V., Beale, D. J., Karpe, A. V., Eri, R. D., & Stanley, R. A. (2020) · Nutrients · doi:10.3390/nu12082380 · Cited by 37
Jones, L., Kumar, J., Mistry, A., Sankar Chittoor Mana, T., Perry, G., Reddy, V. P., & Obrenovich, M. (2019) · Biomedicines · doi:10.3390/biomedicines7020024 · Cited by 34
Jeong, J., Ganesan, R., Jin, Y.-J., Park, H., Min, B. H., Jeong, M. K., Yoon, S. J., Choi, M., Choi, J., Moon, J. H., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174968 · Cited by 34
Song, T., Guan, X., Wang, X., Qu, S., Zhang, S., Hui, W., Men, L., & Chen, X. (2021) · The FASEB Journal · doi:10.1096/fj.201903129rrr · Cited by 34
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension
Chen, Y.-H., Wen, Y., Meng, L., Zhong, J., & Liu, X.-Y. (2022) · Nutrients · doi:10.3390/nu14204278 · Cited by 39
Gut microbiota and myocardial fibrosis
Han, X., Yang, F., & Bao, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175355 · Cited by 35
Chen, L., Sun, X., Khalsa, A. S., Bailey, M. T., Kelleher, K. J., Spees, C., & Zhu, J. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114066 · Cited by 31
Dąbek, A., Kaczmarczyk, O., Woźniakiewicz, M., Paśko, P., Dobrowolska‐Iwanek, J., Woźniakiewicz, A., Piątek-Guziewicz, A., Zagrodzki, P., & Zwolinska-Wcislo, M. M. (2022) · Biology · doi:10.3390/biology11010108 · Cited by 35
Huang, S., He, Y., Chen, P., Liu, K., & Shaukat, A. (2023) · Animal Diseases · doi:10.1186/s44149-023-00089-5 · Cited by 36
The emerging role of microbiota derived SCFAs in neurodegenerative disorders
Wachamo, S., & Gaultier, A. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101012 · Cited by 36
In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells
PATTAYIL, L., & BALAKRISHNAN-SARASWATHI, H.-T. (2019) · Anticancer Research · doi:10.21873/anticanres.13528 · Cited by 32
Chen, S.-M., Guo, B.-J., Feng, A.-Q., Wang, X., Zhang, S.-L., & Miao, C. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00211-0 · Cited by 34
Gio-Batta, M., Spetz, K., Barman, M., Bråbäck, L., Norin, E. L., Björkstén, B., Wold, A. E., & Sandin, A. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000520149 · Cited by 29
The gut–heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development
Abdulrahim, A. O., Doddapaneni, N. S. P., Salman, N., Giridharan, A., Thomas, J., Sharma, K., Abboud, E., Rochill, K., Shreelakshmi, B., Gupta, V., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002789 · Cited by 33
Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids
Fitzgerald, B. G., Govind, M., Firth, I. J., Herold, L., Froment, J., Vancuren, S. J., Allen‐Vercoe, E., Kimber, M. S., & Sorbara, M. T. (2025) · Microbiome · doi:10.1186/s40168-025-02220-9 · Cited by 35
Paciolla, C., Manganelli, M., Chiano, M. D., Montenegro, F., Gallone, A., Sallustio, F., & Guida, G. (2025) · Cells · doi:10.3390/cells14221823 · Cited by 35
Hersi, F., Elgendy, S. M., Shamma, S. A. A., Altell, R. T., Sadiek, O., & Omar, H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120573 · Cited by 29
Shegani, A., Kealey, S., Luzi, F., Basagni, F., Machado, J. D. M., Ekici, S. D., Ferocino, A., Gee, A. D., & Bongarzone, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00398 · Cited by 28
Epigenetic Aberrations in Major Psychiatric Diseases Related to Diet and Gut Microbiome Alterations
Nohesara, S., Abdolmaleky, H. M., & Thiagalingam, S. (2023) · Genes · doi:10.3390/genes14071506 · Cited by 32
Inflammatory Bowel Diseases: The Role of Gut Microbiota
Musis, C. D., Granata, L., Dallio, M., Miranda, A., Gravina, A. G., & Romano, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200420144128 · Cited by 27
Kumari, B., Kumari, U., Singh, D. K., Husain, G. M., Patel, D. K., Shakya, A., Singh, R. B., Modi, G. P., & Singh, G. K. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303262653231120043819 · Cited by 27
González‐Bosch, C., Zunszain, P. A., & Mann, G. E. (2023) · Pathogens · doi:10.3390/pathogens12030486 · Cited by 27
Immune System Efficiency in Cancer and the Microbiota Influence
Barbosa, A. M., Gomes-Gonçalves, A., Castro, A. G., & Torrado, E. (2021) · Pathobiology · doi:10.1159/000512326 · Cited by 25
Metadata
- Authors
- Yuille, S., Reichardt, N., Panda, S., Dunbar, H., & Mulder, I. E.
- Corresponding author
- Mulder, Imke E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-07-27
- Volume
- 13
- Issue
- 7
- Pages
- e0201073
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6063406
- OpenAlex
- W2884838967
- Cited by
- 257
- References
- 48
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 46 · 2023: 48 · 2022: 34 · 2021: 27 · 2020: 37 · 2019: 18 · 2018: 1
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- histone deacetylase inhibitors, gut microbiota, class I HDACs, class II HDACs, short-chain fatty acids, butyrate, valeric acid, hexanoic acid, cell-free supernatant, microbial consortia, epigenetic regulation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Culture Media, Histone Deacetylases, Humans, Pentanoic Acids, Cell Culture Techniques, HT29 Cells, Butyric Acid, Megasphaera, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
